Related references
Note: Only part of the references are listed.The Tethering Arm of the EGF Receptor Is Required for Negative Cooperativity and Signal Transduction
Sangeeta Adak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Deric L. Wheeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
In Vitro Enzymatic Characterization of Near Full Length EGFR in Activated and Inhibited States
Chen Qiu et al.
BIOCHEMISTRY (2009)
Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
Natalia Jura et al.
CELL (2009)
The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding
Jennifer L. Macdonald-Obermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Protein Array Identification of Substrates of the Epstein-Barr Virus Protein Kinase BGLF4
Jian Zhu et al.
JOURNAL OF VIROLOGY (2009)
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Monica Red Brewer et al.
MOLECULAR CELL (2009)
Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib
Tona M. Gilmer et al.
CANCER RESEARCH (2008)
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Mohammad Azam et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS
Udayan Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Drug insight: panitumumab, a human EGFR-targeted monoclonal antibody with promising clinical activity in colorectal cancer
Max Mano et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Drug insight: intracellular inhibitors of HER2 - clinical development of lapatinib in breast cancer
David A. Cameron et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system
Jennifer L. Macdonald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation
Kristina W. Thiel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Xuewu Zhang et al.
NATURE (2007)
Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification
Takafumi Okabe et al.
CANCER RESEARCH (2007)
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity
Cai-Hong Yun et al.
CANCER CELL (2007)
Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib
Roseann Mulloy et al.
CANCER RESEARCH (2007)
Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib
Kendall D. Carey et al.
CANCER RESEARCH (2006)
Phosphoproteomic analysis of Her2/neu signaling and inhibition
Ron Bose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Xuewu Zhang et al.
CELL (2006)
A Src-like inactive conformation in the Abl tyrosine kinase domain
Nicholas M. Levinson et al.
PLOS BIOLOGY (2006)
Chemical rescue of a mutant enzyme in living cells
YF Qiao et al.
SCIENCE (2006)
High yield bacterial expression of active c-Abl and c-Src tyrosine kinases
MA Seeliger et al.
PROTEIN SCIENCE (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson et al.
MOLECULAR CELL (2003)
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor
J Stamos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structure and function in rhodopsin:: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
PJ Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α
TPJ Garrett et al.
CELL (2002)
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains
H Ogiso et al.
CELL (2002)
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
J Schlessinger
CELL (2002)
Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail
DX Wang et al.
BIOCHEMISTRY (2001)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
Share Paper
